Clinical trial Recruiting at 1 site Interventional Ages 16 and up Women only

Using cerclage to prevent extreme preterm birth in twin pregnancies with a short cervix

Official title: The Effectiveness of Cerclage for the Reduction of Extreme Preterm Birth and Perinatal Mortality in Twin Pregnancies With a Short Cervix or Dilatation

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT05968794 · Data updated 2026-11-12

This study is testing if a special stitch called cerclage can help prevent extremely early births in women carrying twins who have a short cervix.

Quick facts

Study typeInterventional
Ages16 Years and up
SexWomen only
Enrollment238 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations13 sites (Antwerp and 12 other locations)
StatusRecruiting
StartedMay 15, 2023
Main results expectedJanuary 1, 2028
Study endsDecember 1, 2028
Registry record updatedNovember 13, 2023
Trial IDNCT05968794 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women over 16 years of age with a twin pregnancy and either a short cervix or cervical dilatation detected during routine ultrasound.

Probably not a fit

Patients with mono-amniotic twin pregnancies or those with significant fetal abnormalities or signs of preterm labor will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of a vaginal cerclage in preventing extreme preterm birth (before 28 weeks) in women with twin pregnancies who have a short cervix or cervical dilatation. Participants will be randomly assigned to receive either the cerclage intervention or standard treatment without cerclage. The study is motivated by the high incidence of extreme preterm births in twin pregnancies and seeks to provide evidence on whether cerclage can reduce these occurrences and improve neonatal outcomes. The trial will be conducted in multiple medical centers in the Netherlands, leveraging existing surgical expertise in the participating hospitals.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce the rates of extreme preterm birth and improve the health outcomes for twins born to mothers with a short cervix.

How similar studies have gone: While the use of cerclage in singleton pregnancies has shown effectiveness, this approach in twin pregnancies is less established, making this study a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Women (\> 16 years of age) with a twin pregnancy and:

* an asymptomatic short cervix at routine ultrasound investigation (below 24 weeks of gestation) OR
* cervical dilatation (below 24 weeks of gestation)

Exclusion Criteria:

* Women with a mono-amniotic twin pregnancy
* Women with twin pregnancy in which one or both children are diagnosed with a major structural, congenital or chromosomal abnormality that is likely to influence the composite adverse neonatal outcome.
* Women with dilatation of the cervix and signs of clinical intra-uterine infection, defined by the presence of fever ≥ 38 degrees Celsius.
* Women with overt symptoms of preterm labour at time of measurement of short cervix (regular contractions, PPROM, recurrent blood loss).
* Women with a placenta previa, defined as a placenta position covering the internal ostium of the cervix.
* Women who do not master the Dutch of English language and therefore not able to give written consent

Where it's running

  • University Medical Center Amsterdam
    Amsterdam, Netherlands
    Recruiting
  • University Medical Center Antwerpen
    Antwerp, Belgium
    Not yet recruiting
  • University Medical Center Sint-Lucas Brugge
    Bruges, Belgium
    Not yet recruiting
  • Hospital Oost-Limburg Genk
    Genk, Belgium
    Not yet recruiting
  • University Medical Center Gent
    Ghent, Belgium
    Not yet recruiting
  • University Medical Center Leuven
    Leuven, Belgium
    Not yet recruiting
Show 7 more locations
  • University Medical Center Groningen
    Groningen, Netherlands
    Not yet recruiting
  • University Medical Center Leiden
    Leiden, Netherlands
    Not yet recruiting
  • University Medical Center Maastricht
    Maastricht, Netherlands
    Not yet recruiting
  • Radboud University Medical Center
    Nijmegen, Netherlands
    Not yet recruiting
  • Erasmus Medical Centre
    Rotterdam, Netherlands
    Not yet recruiting
  • University Medical Center Utrecht
    Utrecht, Netherlands
    Not yet recruiting
  • Maxima Medical Centre
    Veldhoven, Netherlands
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.